Interleukin-6 in oral diseases: a review

被引：123

作者：

Nibali, L. ^{[1
,2
]}

Fedele, S. ^{[2
,3
]}

D'Aiuto, F. ^{[1
,2
]}

Donos, N. ^{[1
,2
]}

机构：

[1] UCL, Periodontol Unit, UCL Eastman Dent Inst, London WC1X 8LD, England

[2] UCL, Dept Clin Res, UCL Eastman Dent Inst, London WC1X 8LD, England

[3] UCL, Oral Med Unit, UCL Eastman Dent Inst, London WC1X 8LD, England

来源：

ORAL DISEASES | 2012年 / 18卷 / 03期

关键词：

interleukin-6; oral diseases; periodontitis; lichen planus; oral cancer; Sjogren's syndrome; TUMOR-NECROSIS-FACTOR; FUNCTIONAL GENE POLYMORPHISMS; GINGIVAL CREVICULAR FLUID; B-DEPENDENT CYTOKINES; RECEPTOR IL-6R GENE; HUMAN DENTAL-PULP; LICHEN-PLANUS; FACTOR-ALPHA; PERIODONTAL-DISEASE; TNF-ALPHA;

D O I：

10.1111/j.1601-0825.2011.01867.x

中图分类号：

R78 [口腔科学];

学科分类号：

1003 ;

摘要：

Interleukin-6 (IL-6) is a pleomorphic cytokine involved in a number of physiologic and pathologic processes including response to trauma and infection and development and progression of inflammation and malignancy. IL-6 is emerging as an important mediator and novel therapeutic target for chronic inflammatory diseases and cancer. The present study reviews the available evidence regarding the association between IL-6 and a range of oral diseases including infections (periodontal disease and endodontic infections), immunologically mediated disorders (oral lichen planus and Sjogren's syndrome) and malignancy (oral cancer and precancer). The role of common genetic variants of IL-6 in determining individual susceptibility to certain oral diseases, as well as novel therapeutic strategies based on IL-6 inhibition are also discussed. Oral Diseases (2012) 18, 236-243

引用

页码：236 / 243

页数：8

共 50 条

[31] Inappropriately normal plasma ACTH and cortisol concentrations in the face of increased circulating interleukin-6 concentration in exercise in patients with sarcoidosis
Mastorakos, George
Paltoglou, George
Greene, Maria
Ilias, Ioannis
Papamichalopoulos, Antonios
Dimopoulos, Stavros
Pouliou, Eleni
Fatouros, Ioannis G.
Nanas, Serafim
STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS, 2013, 16 (02): : 202 - 210
[32] Oral but Not Intravenous Glucose Acutely Decreases Circulating Interleukin-6 Concentrations in Overweight Individuals
Manning, Patrick J.
Sutherland, Wayne H. F.
Williams, Sheila M.
de Jong, Sylvia A.
Hendry, Gavin P.
PLOS ONE, 2013, 8 (06):
[33] Mechanism for bone invasion of oral cancer cells mediated by interleukin-6 in vitro and in vivo
Okamoto, M
Hiura, K
Ohe, G
Ohba, Y
Terai, K
Oshikawa, T
Furuichi, S
Nishikawa, H
Moriyama, K
Yoshida, H
Sato, M
CANCER, 2000, 89 (09) : 1966 - 1975
[34] Interleukin-6 and Macular Edema: A Review of Outcomes with Inhibition
Yang, Janine Yunfan
Goldberg, David
Sobrin, Lucia
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
[35] Interleukin-6 in pregnancy and gestational disorders
Prins, Jelmer R.
Gomez-Lopez, Nardhy
Robertson, Sarah A.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2012, 95 (1-2) : 1 - 14
[36] Targeting interleukin-6 in autoimmune uveitis
Mesquida, Marina
Molins, Blanca
Llorenc, Victor
Sainz de la Maza, Maite
Adan, Alfredo
AUTOIMMUNITY REVIEWS, 2017, 16 (10) : 1079 - 1089
[37] Salivary Interleukin-6 Levels in Patients with Periodontitis Stage IV
Hadzic, Zerina
Pasic, Enes
Hukic, Mirsada
Vukelic, Mirjana Gojkov
Hadzic, Sanja
MEANDROS MEDICAL AND DENTAL JOURNAL, 2021, 22 (02): : 140 - 147
[38] Significance of interleukin-6 (IL-6) in breast cancer (review)
Knuepfer, Heike
Preiss, Rainer
BREAST CANCER RESEARCH AND TREATMENT, 2007, 102 (02) : 129 - 135
[39] Interleukin-6 and melanoma
Hoejberg, Lise
Bastholt, Lars
Schmidt, Henrik
MELANOMA RESEARCH, 2012, 22 (05) : 327 - 333
[40] Expression, polymorphism and methylation pattern of interleukin-6 in periodontal tissues
Stefani, Florenca Abdanur
Viana, Michelle Beatriz
Dupim, Ana Carolina
Ricieri Brito, Joao Artur
Gomez, Ricardo Santiago
da Costa, Jose Eustaquio
Moreira, Paula Rocha
IMMUNOBIOLOGY, 2013, 218 (07) : 1012 - 1017

← 1 2 3 4 5 →